Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar
Overactive Bladder Common in Postacute COVID-19 Syndrome
COVID-19 may lead to new or worsening urinary symptoms in men and women